Prevalence and impact of childhood adversities and post-traumatic stress disorder in women with fibromyalgia and chronic widespread pain. by Coppens, E et al.
 
 
 
1 
 
Prevalence and impact of childhood 
adversities and post-traumatic stress 
disorder in women with fibromyalgia 
and chronic widespread pain 
Eline Coppens (1,2), MA;  Peter Van Wambeke (1,3), MD; Bart Morlion (1,4), MD, PhD; 
Nathalie Weltens (5), MSc; Huynh Giao Ly (5), MSc, PhD; Jan Tack (5), MD, PhD; Patrick 
Luyten (2,6,7)*, PhD; Lukas Van Oudenhove* (5, 8), MD, PhD 
 
(1) The Leuven Centre for Algology & Pain Management, University Hospitals Leuven, 
Belgium 
(2) Faculty of Psychology and Educational Sciences, KU Leuven, Belgium 
(3) Department of Physical Medicine and Rehabilitation, University Hospitals Leuven, 
Belgium 
(4) Department of Anesthesiology and Algology, KU Leuven, Belgium 
(5) Translational Research Center for Gastrointestinal Disorders (TARGID), Department of 
Clinical & Experimental Medicine, KU Leuven, Belgium 
(6) Research Department of Clinical, Educational and Health Psychology, University College 
London, UK 
(7) Assistant Professor, Adjunct, Yale Child Study Center, New Haven, CT, USA 
(8) Consultation-Liaison Psychiatry, University Psychiatric Center KU Leuven, campus 
Gasthuisberg, Leuven, Belgium 
* joint senior authorship 
 
Source of Funding : Research-Foundation Flanders Bijzondere Onderzoeksbeurs (Eline 
Coppens) – KU Leuven Special Research Fund (Bijzonder Onderzoeksfonds, BOF) (Lukas 
Van Oudenhove) 
 
We declare no conflict of interest. 
 
In press: European Journal of Pain 
 
Correspondence: Mrs. Eline Coppens, UZ Leuven Campus Pellenberg, LAC, Weligerveld 1, 
3212 Pellenberg, Belgium – eline.coppens@kuleuven.be – tel +32 16 338451 – fax +32 16 
338453 
Email addresses co-authors: peter.vanwambeke@uzleuven.be, bart.morlion@uzleuven.be, 
nathalie.weltens@kuleuven.be, huynghgiao.ly@kuleuven.be, jan.tack@kuleuven.be, 
patrick.luyten@kuleuven.be, lukas.vanoudenhove@kuleuven.be 
 
 
 
2 
 
 
Abstract 
Objective 
This study investigates the prevalence of different types of childhood adversities (CA) and 
posttraumatic stress disorder (PTSD) in female patients with Fibromyalgia or Chronic 
Widespread Pain (FM/CWP) compared to patients with Functional Dyspepsia (FD) and 
achalasia. In FM/CWP, we also investigated the association between CA and PTSD on the 
one hand and pain severity on the other. 
Methods 
Patient samples consisted of 154 female FM/CWP, 83 female FD and 53 female achalasia 
patients consecutively recruited from a tertiary care hospital. Well-validated self-report 
questionnaires were used to investigate CA and PTSD.  
Results 
Forty-nine percent of FM/CWP patients reported at least 1 type of CA, compared to 39.7% of 
FD patients and 23.4% of achalasia patients (p<0.01). The prevalence of CA did not differ 
significantly between FM/CWP and FD, but both groups had a higher prevalence of CA 
compared to both achalasia and healthy controls (p<.01). FM/CWP patients were 6 times 
more likely to report PTSD than both FD (p<.001) and achalasia (p<.001) patients. 
Conclusion 
 In FM/CWP, PTSD co-morbidity, but not CA, was associated with self-reported pain severity 
and PTSD severity mediated the relationship between CA and pain severity. In summary, the 
prevalence of CA is higher in FM/CWP compared to achalasia, but similar to FD. However, 
PTSD is more prevalent in FM/CWP compared to FD and associated with higher pain 
intensity in FM/CWP.  
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Significance statement: 
As expected and has been shown in other functional disorders, we found elevated levels of 
childhood adversity in FM/CWP patients. Results of this study however suggest that the 
impact of childhood adversity (i.e. whether such events have led to the development of PTSD 
symptoms), rather than the mere presence of such adversity, is of crucial importance in 
FM/CWP patients. Screening for PTSD symptoms should be an essential part of the 
assessment process in patients suffering from FM/CWP, and both prevention and intervention 
efforts should take into account PTSD symptoms and their impact on pain severity and 
general functioning.  
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Introduction 
Fibromyalgia is described as a syndrome based on American College of Rheumatology 
(ACR) criteria for fibromyalgia (FM) (Wolfe et al., 1990). Patients with chronic widespread 
pain with a minimal duration of three months and at least 11 of 18 specified tender points 
present fulfil the criteria. Patients that do not fulfil the criterion of 11 tender points are 
typically diagnosed with chronic widespread pain (CWP). The prevalence of CWP in the 
European population is estimated to be as high as 13% (Branco et al., 2010), while the 
prevalence of FM is estimated to be around 3% (Branco et al., 2010; Spaeth 2009), with a 
female/male ratio of 9:1 (Hauser et al., 2011; Yunus 2001). FM/CWP are considered to be 
part of a larger group of functional somatic syndromes (FSS) (Fink et al., 2005; Wessely et 
al., 1999) or central sensitivity syndromes (Yunus 2001).  
A history of childhood adversities (CA) has been shown to elevate the risk to develop CWP 
(Jones et al., 2009), with the prevalence of CA in FM typically ranging between 16% and 
60% (Bohn et al., 2013; Davis et al., 2005; Häuser et al., 2011; Van Houdenhove et al., 2001; 
Walker et al., 1997). It has been established that CA prevalence of FM/CWP is higher 
compared with healthy control groups (Häuser et al., 2011). It is however not clear whether 
the CA prevalence in FM/CWP is different compared to other FSS, and whether and how CA 
may play a role in the pathogenesis of these disorders. 
Second, given the high prevalence of CA in FM/CWP, it is surprising that most studies in this 
area have not assessed the prevalence of post-traumatic stress disorder (PTSD) symptoms. 
The few existing studies found a high prevalence of PTSD in FM, ranging from 45 to 57% 
(Cohen et al., 2002; Häuser et al., 2013; Sherman et al., 2000), and PTSD has been shown to 
be associated with symptom severity in FM (Amir et al., 1997; Dell'Osso et al., 2010; 
Sherman et al., 2000). 
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Given the above limitations in the literature, the primary aim of this study was to compare the 
prevalence of CA and PTSD in FM/CWP with (a) patients with Functional Dyspepsia (FD), 
another highly prevalent FSS characterized by upper gastrointestinal tract symptoms, and (b) 
patients suffering from a chronic disabling somatic disorder of the upper gastrointestinal tract 
namely achalasia. Achalasia, like FM/CWP, is a chronic disorder, associated with comparable 
impairment in quality of life (Ben-Meir et al., 2001; Meshkinpour et al., 1996). It is a rare 
motility disorder of the esophagus characterized by absence of peristalsis and impaired 
relaxation of the lower esophageal sphincter (Boeckxstaens et al., 2014).  
Based on the literature reviewed above, we hypothesized that levels of CA would be elevated 
in FM/CWP compared to achalasia patients. Based on other studies comparing CA prevalence 
in different FSS (Afari et al., 2014), we hypothesized similar levels of CA in FM/CWP 
compared with FD. The second aim of this study was to investigate the relationship between 
CA and pain severity in FM/CWP as well as the possible role of PTSD in this relationship. 
We hypothesized a dose-response relationship between the number of CAs and pain severity 
in FM/CWP, in line with studies in other FSS (Bradford et al., 2012; Drossman 2011). 
Moreover, we hypothesized that PTSD would play both a moderating and mediating role in 
the relationship between CA and pain severity. Similar to other studies, we expected high 
levels of PTSD in FM/CWP (Cohen et al., 2002; Häuser et al., 2013; Roy-Byrne et al., 2004) 
compared to both FD and achalasia patients. Finally, we also hypothesized a dose-response 
relationship between the presence and severity of PTSD and pain severity in FM/CWP (Roy-
Byrne et al., 2004).  
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Methods 
Participants and procedures 
Participants in the FM/CWP sample were 233 consecutive newly diagnosed female patients 
with chronic diffuse musculoskeletal pain symptoms who were referred to a tertiary care 
centre for chronic pain at the University Hospitals Leuven (Belgium) in the period 2011-2014. 
Exclusion criteria were: not being able to understand and write the Dutch language, and 
psychiatric comorbidity at the initial consultation. Patients were carefully screened through a 
clinical examination performed by the physician using the 1990 ACR-criteria for FM, and a 
clinical examination for CWP (Wolfe et al., 1990). As described in Wolfe et al. (Wolfe et al., 
1990), for CWP, pain has to be present axially, in the left and right side of the body as well as 
above and below the waist. To avoid gender differences as a potentially confounding factor 
for the analyses within the FM/CWP group, we decided to exclude the few male patients (5) 
referred to the clinic. As noted above, the vast majority of FM/CWP patients are women, with 
a 9:1 ratio (Yunus 2001). Patients were on average 42.46 years old (SD = 10.5). Thirty 
patients did not fully fulfil the ACR-criteria for FM and were diagnosed with CWP. Analyses 
showed no differences between FM and CWP with regard to different types of CA, PTSD as 
well as pain severity. Therefore, we report results on both samples combined.   
Our control groups were recruited in the period 2009-2012. The FD sample consisted of 108 
patients (83 (77%) women; mean age 41.9 ± 14.97 years), consecutively recruited at the 
neurogastroenterology outpatient clinic of the University Hospitals Leuven.  
The achalasia sample consisted of 100 patients (53 (53%) women; mean age 53.79 ± 17.17 
years), consecutively recruited at the general gastroenterology and neurogastroenterology 
outpatient clinic of the University Hospitals Leuven.  
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Demographic characteristics are presented in Table 1.  
Measures 
Following informed consent, patients filled out well-validated Dutch versions of the following 
self-report questionnaires. First, CA was assessed using the short form of the Childhood 
Trauma Questionnaire [CTQ; (Bernstein D 1998; Bernstein et al., 2003)]. The CTQ measures 
5 categories of CA, i.e., emotional, physical, and sexual abuse as well as emotional and 
physical neglect. Three variables assessing CA were created. First, we used the cut-off scores 
as defined by Heim (Heim 2006) and described in the CTQ manual (Bernstein D 1998) to 
identify patients suffering from moderate-to-severe CA in each category. Then, we created a 
dichotomous CA variable with 0=no CA and 1=at least one type of CA (‘with and without 
CA’). Second, we created an ordinal variable based on the number of CAs reported (0, 1, 2 
and 3 or more CAs) (‘number of CAs’). Finally, we also calculated a total CA score (‘CA 
severity’) based on a sum score of all scores on the CTQ subscales. Given that this variable 
was highly skewed, we used the log transformed total score of the CTQ in all analyses with 
this variable.  
PTSD was measured by the Self-Rating Inventory for PTSD (PTSD-ZIL) (Hovens et al., 
2000). The cut-off score used to diagnose PTSD is 52 (Hovens et al., 2000); the log 
transformed total score of the PTSD-ZIL was used as a continuous measure of PTSD severity.   
Pain severity in FM/CWP patients was assessed using the McGill Pain Questionnaire (MPQ-
Dutch Language Version) (van der Kloot and Vertommen 1989).  
For further details, see Supplementary Material. 
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Statistical analysis 
First, we investigated the prevalence of different types of CA in the three samples using χ²-
square tests on a 2 (with versus without CA) x 3 (group) contingency table. This test was 
followed by 2 planned contrasts consisting of pairwise comparisons (with Bonferroni 
correction) between the FM/CWP sample on the one hand and the FD and achalasia samples 
on the other, controlling for age differences between groups when appropriate (i.e. in case of 
the FM-achalasia comparison, see below). Further, we investigated the association between 
CA and pain severity in FM/CWP using a t-test comparing pain severity between FM/CWP 
with and without CA. We also used ‘CA severity’ as independent variable in linear regression 
analysis with pain severity as the dependent variable. Finally, we investigated a possible dose-
response relationship between the number of CAs and pain severity. The number of CAs was 
entered into an ANOVA followed by post-hoc t-tests with Bonferroni correction to investigate 
potential group differences with pain severity as the dependent variable. Effect sizes of group 
differences are reported as Cohen’s d (for effect size interpretation see Supplementary 
Material). 
Second, for PTSD, we used the same strategy as described above to compare overall PTSD 
prevalence in FM/CWP with FD and achalasia using χ2-tests to test for differences across the 
3 samples followed by 2 pairwise comparisons with Bonferroni correction as planned 
contrasts. Further, we compared PTSD severity in FM/CWP with the two other samples. For 
this purpose, we used ANCOVA, followed by 2 planned contrasts using t-tests with 
Bonferroni correction. The prevalence of PTSD and PTSD severity in FM/CWP with and 
without CA was investigated using χ²-square and t-tests, respectively. The relationship 
between the number of CAs and PTSD severity was investigated using ANOVA and the 
relationship between CA- and PTSD severity was investigated using linear regression analysis 
with PTSD severity as dependent variable. Finally, we investigated the association between 
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PTSD and pain severity in FM/CWP using a t-test comparing pain severity between FM/CWP 
with and without PTSD. We also used ‘PTSD severity’ as independent variable in linear 
regression analysis with pain severity as the dependent variable. To investigate whether PTSD 
moderated or mediated the relationship between CA and pain severity in FM/CWP, we used 
the PROCESS macro developed by Hayes (Hayes 2012).  
Results 
In total, 197 patients initially agreed to participate in the study (85%). Of these 197 patients, 
38 patients (19%) did not return complete data (more than 5% missing data), and were 
therefore excluded from further analysis. 
Demographics 
We controlled for age when comparing the FM with the achalasia sample because there was a 
significant age difference between the different groups (F(2)=24.84, p<.001), driven by 
significant differences between participants in the achalasia sample on the one hand (mean 
age 53.8±1672) and in both the FM (42.5±10.5, p<.001) and FD (41.9±15.0, p<.001) samples. 
There were no significant differences in age for FM and FD patients (p=0.98) (see table 1).  
Groups differed also on work status (χ2=37.52, p<0.001). There was a greater proportion of 
FM patients that had a job and received an allowance (health insurance or work 
compensation) compared with the other groups. More FD patients were pensioned (z-test, see 
table 1). We investigated in an ANOVA the relationship between work status and CA severity 
but found no significant differences (F(2)=2,25, p=.11). We also investigated a possible 
relationship between work status and the different types of CA using χ²-square tests on a 2 
(with versus without CA)x 3 (group) contingency table but again, found no differences. 
Hence, further analyses were only controlled for age. 
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Prevalence and impact of CA  
Prevalence of CA 
Forty-nine percent of FM/CWP patients reported at least one type of CA compared to 39.7% 
of FD, and 23.4% of achalasia patients (χ2=10.22, p=0.006) (Table 2). As hypothesized, the 
prevalence of CA was not significantly higher in FM/CWP compared with FD (OR=1.48, 
[0.85-2.57], p=0.33), but the prevalence of CA in FM/CWP was significantly higher than in 
achalasia (OR= 4.35, [1.87-10.12], p=0.0014 Bonferroni corrected) (Table 2).  
With regard to specific types of CA, the prevalence of sexual abuse, emotional abuse, and 
emotional neglect was significantly higher in FM/CWP compared to achalasia (ORs ranging 
from 3.38 to 8.37), but no significant differences were found for physical abuse or physical 
neglect (Table 2).  
Association between CA and pain severity in FM 
There was no relationship between CA severity and both quantitative (ß=.06, p=.45) and 
qualitative pain severity (ß=.03, p=.73) in FM/CWP. Neither was there a dose-response 
relationship between CA severity and both quantitative (F(3)=.75, p=.53) and qualitative pain 
severity in FM/CWP (F(3)=.87, p=.46). 
Prevalence and impact of PTSD  
Prevalence 
The prevalence of PTSD was 26.0% in FM/CWP, 4.9% in FD and 12.2% in achalasia 
(χ2=17.61, p<0.001). FM/CWP patients were about 5 to 7 times more likely to meet PTSD-
criteria compared to FD (OR= 6.98, [2.38-20.52], p<0.001) and achalasia (OR= 4.60, [1.55-
13.66], p<0.001), respectively. An ANOVA for group differences in PTSD severity was also 
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significant (F(2)=35.84, p<.001, ῃ2=.20). Planned contrasts with Bonferroni correction for 
multiple testing revealed that FM/CWP reported higher PTSD severity (3.75±0.27) compared 
to both FD (3.47±0.26), d=1.05) and achalasia (3.50±0.32), d=.88) (both p<.001) (Figure 1). 
Further, FM/CWP with CA compared to FM/CWP without CA reported higher rates of PTSD 
(34% versus 17.9%, χ2=5.29, p=.021) and higher PTSD severity (3.82 (± .27) vs. 3.68 (± .25), 
t(150)=-3.37, p=.001).
1
 
Finally, there was a dose-response relationship between the number of CAs and PTSD 
severity in FM/CWP (F(3)=3.88, p=.01, ῃ2=.07) (Figure 2). Post-hoc tests revealed a 
significant difference between patients without any CA and those reporting three or more CA 
categories (p=.04, mean score 3.68 (± .25) vs. 3.84 (± .26), d =-.65). There also was a dose-
response relationship between CA severity and PTSD severity (ß=.22, p=.006). 
Association between PTSD and pain severity in FM/CWP 
Regression analyses showed a significant relationship between PTSD severity in FM/CWP 
and both quantitative (ß=.21, p=.027) and qualitative (ß=.37, p<.001) pain ratings. This was 
confirmed by the finding that FM/CWP patients with PTSD reported higher pain levels 
compared to FM/CWP patients without PTSD, representing medium effect sizes, both for 
quantitative pain (70.0 (±14.0) vs. 62.4 (±14.4), t(152)=-2.91, p=.004, d =.54, CI=1.71-2.79) 
and for qualitative pain (36.5 (±9.6) vs. 30.4 (±9.4), t(152)=-3.51), p=.001, d =.65, CI=0.84-
2.14). 
Finally, we found an indirect effect of CA severity on qualitative pain reports through PTSD 
severity (ß= 2.15, CI [.65-4.48], К2=.09, CI=.03-.17). We also found a similar indirect effect 
of CA severity on quantitative pain through PTSD severity (ß= 1.60, CI [.25-4.65], К2=.04, 
                                                          
1
 See Supplementary Materials for the prevalence of PTSD in relation to different types of 
CA.  
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CI=[.01-.11]). We did not find any significant moderation effects of PTSD on the relationship 
of CA and pain severity. 
Discussion 
The primary aim of this study was to compare the prevalence of different types of CA in 
female FM/CWP and female patients with another FSS (FD), and with a chronic organic 
condition (achalasia). Results showed that the prevalence of CA did not differ between 
FM/CWP and FD. Further, FM/CWP patients had higher levels of all types of CA compared 
to achalasia. The odds of reporting at least one type of CA was four times higher compared to 
achalasia patients. In the present study, about half of all FM/CWP patients reported at least 
one type of CA. This finding is consistent with figures reported in other studies and meta-
analyses (Borsini et al., 2013; Davis et al., 2005; Häuser et al., 2011), although most other 
studies did not investigate emotional CA (Häuser et al., 2011). A recent European study 
investigating the prevalence of CA in FM in tertiary care (Bohn et al., 2013) with the CTQ 
(Bernstein D 1998) reported similar prevalence rates of all types of CA as in the current 
study.  
The second aim of this study was to investigate the relationship of CA with pain severity in 
FM/CWP. No relationship was found between the presence or severity of CA and pain 
severity in FM/CWP. This was somewhat unexpected because it contrasts with findings 
reported by Loevinger et al. (Loevinger 2012). These authors identified different clusters of 
FM, with a cluster of patients reporting most pain and disability having the highest scores on 
CA. Yet, other studies have also typically failed to find a relationship between CA and pain 
severity in FM (Aaron et al., 1997; Waller et al., 2015). It is possible that other measures, e.g. 
disability, are more appropriate than pain intensity to demonstrate an impact of CAs on the 
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clinical outcome of FMS-patients. However, we also did not find a relationship between CA 
and FM disability (measured by FIQ) in our data (data not shown). 
Further, the prevalence of PTSD in this study was lower than in other studies using other self-
report questionnaires (Cohen et al., 2002; Häuser et al., 2013; Sherman et al., 2000), but 
similar rates were found in a study by Raphael et al. (Raphael et al., 2006) who did not find 
any current PTSD in FM using a psychiatric interview to assess PTSD. However, in the 
current study, FM/CWP patients were about 6 times more likely to meet PTSD criteria 
compared with FD and achalasia. In addition, in FM/CWP, severity of CA and PTSD were 
strongly associated, as expected. Yet, only PTSD, and not CA, was associated with pain 
severity in FM/CWP. In experimental studies, PTSD has been related to hyposensitivity to 
acute pain (Defrin et al., 2008; Geuze et al., 2007) but in chronic pain, including FM, PTSD 
has been associated with higher pain levels (Amir et al., 1997; Beckham et al., 1997; Häuser 
et al., 2012; Sherman et al., 2000). In this study, PTSD severity mediated the relationship 
between CA and pain severity, despite the lack of a direct relationship between both. This 
may indicate that the impact, rather than the mere presence, of CA is of crucial importance 
when it comes to the influence of CA on pain severity. These findings contrast somewhat with 
a prospective study by Raphael et al. (Raphael and Widom 2011) in which abused and/or 
neglected children were matched with non-abused and non-neglected children of similar age, 
race/ethnicity, gender, and parental social class and followed prospectively into adulthood. 
This study did not find that PTSD mediated the relationship of CA and pain severity in 
adulthood. Yet, in this study more strict criteria for mediation were used requiring a 
significant relationship between the independent and the outcome variable (Baron and Kenny 
1986), while we used more recent state-of-the-art recommendations for testing mediation 
(Preacher and Hayes 2004; Zhao et al., 2010). The mediating role of PTSD in the relationship 
between CA/trauma and pain symptoms has on the other hand been demonstrated in veterans 
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(Campbell et al., 2008; Häuser et al., 2012; Lang et al., 2006). Moreover, there is evidence 
from animal studies that CA may lead to persistent alterations in amygdala development, 
circuitry and function ,with dysfunctional fear regulation as a consequence. More specifically, 
heightened amygdala activity might increase the risk for developing psychopathology such as 
anxiety disorders (Cohen et al., 2013).  
Findings of this study need to be interpreted within the context of some limitations. First, due 
to the retrospective design, we had limited comparable demographic characteristics in all 
three samples. Further, FMS/CWP patients were not assessed for FD and vice versa, nor were 
patients with achalasia tested for FMS/CWP. Second, as all patients were sampled from a 
tertiary care centre, and thus selection or referral bias might have influenced results. This may 
limit the generalizability of findings to FM/CWP patients in primary care or in the general 
population. Third, we used a self-report questionnaire, and not an interview, to assess CA. 
However, the CTQ has been shown to be a reliable and valid instrument to assess CA as is 
shown by its convergence with CA assessed by means of a structured interview (Bernstein et 
al., 2003). Fourth, as the prevalence of CA in this study was lower compared to other studies 
(Bohn et al., 2013), under-reporting (Raphael et al., 2001), rather than over-reporting (Hardt 
and Rutter 2004), might be the case. Fifth, we used achalasia as a chronic organic disease 
control group. Although achalasia is associated with comparable quality of life impairment as 
FM/CWP, is not characterized by chronic pain symptoms. Therefore, the prevalence of CA in 
FM/CWP should be compared with chronic pain symptoms due to organic causes, such as 
rheumatoid arthritis (Walker et al., 1997), in future studies. Sixth, 19% of the participants 
provided more than 5% missing data. This might be a group with higher psychiatric 
comorbidity and/or CA, suffering from cognitive problems e.g. concentration problems. 
Therefore, selection bias can be an issue. Finally, since most studies in this domain, including 
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the present study, are cross-sectional, no firm conclusions can be drawn on the directionality 
of the reported associations. There remains a need for prospective research in this area.  
Despite these limitations, this study showed a similar prevalence of CA in FM/CWP and FD, 
another FSS, but both groups showed significantly higher levels of CA compared to both 
healthy controls and patients with an organic disease. Further, compared with FD and 
achalasia, FM/CWP patients were about 6 times more likely to report PTSD. In FM/CWP, 
there was no direct relationship between CA and pain severity. However, PTSD mediated the 
relationship between CA and pain severity. Together, these results suggest that screening for 
PTSD symptoms should be an essential part of the assessment process in patients suffering 
from FM/CWP, so that patients can be referred for evidence-based treatment to mental health 
care specialists when appropriate (Bisson et al., 2007; Stein et al., 2009). Semi-structured 
interviews such as the MINI (Lecrubier et al., 1997) or well-validated self-report 
questionnaires such as PTSD-ZIL (Hovens et al., 2000) may be used for this purpose. In the 
context of multidisciplinary treatment of FM/CWP, psychotherapeutic strategies need to focus 
on treatment of PTSD symptoms and on the possible impact of these symptoms on pain 
severity. 
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Legends 
 
Figure 1. Posttraumatic stress disorder severity measured by PTSD-ZIL. Boxplot: 
whiskers showing the minimum and maximum, the thick line showing the medium and the 
other lines showing the 1th and3th percentile. On the X-axis the three groups (FM= 
Fibromyalgia/CWP=Chronic widespread pain) and on the Y-axis the PTSD severity scores, 
p<.025 (p<.05 Bonferroni adjusted)* p<.005 (p<.01 Bonferroni adjusted) **  p<.001 
(Bonferroni adjusted) *** 
 
 
Figure 2. Dose-response relationship PTSD/CA in FM/CWP patients. Boxplot: whiskers 
showing the minimum and maximum, the thick line showing the medium and the other lines 
showing the 1th and3th percentile. On the x-axis the number of CA measured by CTQ and on 
the Y-axis the PTSD severity scores, p<.025 (.05 Bonferroni adjusted)* p<.005 (.01 
Bonferroni adjusted)** p<.001 (Bonferroni adjusted)*** 
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